Literature DB >> 10088051

Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease.

M F Weiner1, G Vega, R C Risser, L S Honig, C M Cullum, D Crumpacker, R N Rosenberg.   

Abstract

BACKGROUND: The epsilon 4 allele of apolipoprotein E (apoE epsilon 4) is associated with late-onset Alzheimer's disease (AD), but its relationship to various aspects of AD has become increasingly unclear. We studied the relationship of apoE genotype in AD to educational attainment, history of heart disease or head injury, age of onset, gender, severity of illness, depression, psychotic symptoms, rate of dementia progression, and time from initial evaluation to nursing home placement.
METHODS: ApoE epsilon 4 genotype was determined for 97 clinically diagnosed AD patients and 61 neuropathologically confirmed cases of AD.
RESULTS: Presence of one or more epsilon 4 alleles occurred in 66% of AD cases as compared with 27% in control subjects (allele frequency was .40 for AD, .15 for control subjects). Among AD subjects there was no significant relationship between epsilon 4 alleles and educational attainment, history of heart disease, head injury, age of onset, severity of illness, depression, history of depression, rate of dementia progression, or time to nursing home placement. Marginal correlations emerged between number of epsilon 4 alleles, and delusions (p = .05) and hallucinations (p = .05). There was a trend toward increased epsilon 4 homozygosity in patients with onset between ages 65 and 70 years.
CONCLUSIONS: We did not find that individuals with one or two apoE epsilon 4 alleles differed significantly in clinical course of AD from those without epsilon 4 except for a trend toward increased psychotic symptoms in the group as a whole and an increase in epsilon 4 homozygosity in patients with reported symptom onset in the late 60s.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088051     DOI: 10.1016/s0006-3223(98)00222-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  17 in total

1.  Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.

Authors:  Julia Kim; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 2.  The corticobasal syndrome-Alzheimer's disease conundrum.

Authors:  Anhar Hassan; Jennifer L Whitwell; Keith A Josephs
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

3.  Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Authors:  Winnie Qian; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 4.  Translational research on the way to effective therapy for Alzheimer disease.

Authors:  Roger N Rosenberg
Journal:  Arch Gen Psychiatry       Date:  2005-11

5.  The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.

Authors:  A L Pritchard; J Harris; C W Pritchard; J Coates; S Haque; R Holder; P Bentham; C L Lendon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

Review 6.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Neurobiology of delusions in Alzheimer's disease.

Authors:  Zahinoor Ismail; Minh-Quan Nguyen; Corinne E Fischer; Tom A Schweizer; Benoit H Mulsant; David Mamo
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

8.  Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of AD.

Authors:  Reinhard Heun; Heike Kölsch; Frank Jessen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-05-20       Impact factor: 5.270

Review 9.  Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.

Authors:  Gloria Lena Vega; Myron F Weiner
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

10.  Resolving the relationship between ApolipoproteinE and depression.

Authors:  Michael A Slifer; Eden R Martin; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Neurosci Lett       Date:  2009-03-06       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.